Table Of Content

Breast Cancer Research and Treatment 46: 333, 1997. © 1997 Kluwer Academic Publishers. Printed in the Netherlands. Author index, Volume 46 Barnes S_ 169 Freedman LS 215 Rogers AE 247 Rose DP 225 Cave WT Jr 239 Hanfelt JJ 279 Rygaard K 303 Clarke R 117,255 Hilakivi-Clarke L 143 Connolly JM 225 Schiffer SP 313 Constantinou AI 181 Kritchevsky D 161 Spang-Thomsen M 303 Crowell PL 191 Moon RC 181 Thompson HJ 135 Fay MP 215 Breast Cancer Research and Treatment 46: 335-338, 1997. © 1997 Kluwer Academic Publishers. Printed in the Netherlands. Subject index, Volume 46 adjuvant therapy bone marrow metastases abstracts 30-33 abstracts 60-62 cyclophosphamide dose (NSABP B-25) — BRCAI/2 abstract 26 abstracts 25 aggression breast conservation behavioral correlates of breast cancer risk — abstracts 98-99 human and animal studies 143-159 AIN76, AIN93 caloric restriction see diet and inhibition of experimental mammary alcohol intake carcinogenesis 161-167 behavioral correlates of breast cancer risk — and protection against rodent mammary tumors human and animal studies 143-159 — meta-analyses 215-223 angiogenesis carcinogenesis abstracts 43 design of animal studies on dietary influences animal model studies 247-254 design of experiments on cytotoxic agents 255- monoterpenes in mammary chemoprevention 278 models 191-197 design of diets for animal studies of effects on prevention by retinoids and carotenoids 181-189 carcinogenesis 247-254 prevention by soy isoflavonoids 169-179 effects of exercise on mammary carcinogenesis carcinogens 135-141 DMBA and NMU in animal models of breast overview 117-133 cancer 123-129 special issue — experimental design, nutritional carotenoids and psychosocial research 117-331 unproved in mammary chemoprevention models animal welfare 181-189 colony management in cancer research 313-331 cause-specific failure time antiestrogens in statistical approaches and data analysis of in abstracts 26,83-86 vivo studies 279-302 apoptosis chemoprevention abstracts 28,69-71 molecular alterations in early lesions abstract aromatase inhibitors 25 abstracts 27 monoterpenes d-limonene and perillyl alcohol in axillary nodes animal models 191-197 abstracts 33-34 retinoids and carotenoids in animal models 181- sentinel lymph node metastases — abstracts 24 189 soy isoflavonoids (genistein) — timing 169-179 behaviors chemotherapy correlates of breast cancer risk — human and abstracts 93-97 animal studies 143-159 by monoterpenes d-limonene and perillyl bias alcochol — mechanisms 191-197 in statistical approaches and data analysis of in design of animal model experiments 255-278 vivo studies 279-302 high dose with support — abstracts 72-73 biopsy new drugs and formulations — abstracts 56-60 abstracts 100-102 taxanes abstracts 23 Subject index, Vol. 46 cost-effectiveness ductal carcinoma in situ (DCIS) abstracts 79 abstracts 35-36 radiation unnecessary — abstract 23 d-limonene prevention and chemotherapeutic actions in eicosanoids animal models 191-197 and effects of different fatty acid types on depression mammary tumor promotion 239-246 behavioral correlates of breast cancer risk — endocrine therapy human and animal studies 143-159 abstracts 52-56 detection aromatase inhibitors — abstracts 27 abstracts 102-103 endocrinology development abstracts 110-111 stages — abstracts 43-45 endpoints diet in design of animal model experiments on abstracts 80 cytotoxic agents 255-278 caloric restriction and inhibition of mammary energy restriction carcinogenesis 161-167 see caloric restriction dietary fats effects in breast cancer metastasis environmental risk model 225-237 predicted by bone marrow somatic mutation — dietary omega-3 polyunsaturated fatty acids and abstract 26 delayed tumor development 239-246 epidemiology high maternal fat intake, in utero estrogens, and abstracts 40-41 breast cancer risk 191-214 implications for dietary fat and risk 225-226 meta-analyses of dietary fats and rodent international diet/cancer correlations vs. diet and mammary cancer 215-223 fatty acid studies in rodents 215-223 monoterpenes in mammary chemoprevention estrogen effects models 191-197 of the chemopreventive soy isoflavonoid overview of animal model studies 117-133 genistein 169-179 retinoids and carotenoids in animal estrogen receptors chemoprevention models 181-189 abstracts 20-21,48-50 semipurified AIN76 and AIN93 diets in animal estrogen-regulated behaviors studies 122-123 association with breast cancer risk 143-159 soy isoflavonoids in chemoprevention models estrogens 169-179 and mechanism of risk caused by high maternal diets fat intake 191-214 design for animal studies of effects on exercise carcinogenesis 247-254 effects of duration and intensity on mammary DMBA rat mammary tumors carcinogenesis 135-141 chemoprevention by soy isoflavonoids 169-179 experimental design DNA repair for animal model studies of cytotoxic agents loss of nucleotide excision repair is intrinsic — 255-278 abstract 29 of animal model studies — overview 117-133 drug development statistical approaches and data analysis of in design of animal model experiments on vivo studies 279-302 cytotoxic agents 255-278 drug resistance abstracts 71 familial breast cancer predictive factors — abstracts 64-67 abstracts 25,38-40 Subject index, Vol. 46 fat limonene high maternal fat intake, in utero estrogens, and see d-limonene breast cancer risk 191-214 lobular carcinoma in situ (LCIS) meta-analyses of dietary fats and rodent potential predictor of invasive breast cancer — mammary cancer 215-223 abstract 29 fatty acids dietary omega-3 and delayed tumor development male breast cancer 239-246 abstracts 97 n-3 vs. n-6 polyunsaturated, in enhancing rodent mammary parenchymal structures mammary tumors 215-223 altered by maternal high-fat diet, and breast omega-6 stimulates and omega-3 inhibits cancer risk 191-214 metastasis model 225-237 mammography food restriction abstracts 99-100 and inhibition of experimental mammary MDA-MB-435 human breast cancer cells carcinogenesis 161-167 effects of different fatty acid types on metastasis 225-237 genetic testing membranes abstracts 25,38-40 and effects of different fatty acid types on genetics mammary tumor promotion 239-246 abstracts 111-112 metastasis dissection of breast cancer genome anatomy — abstracts 86-89 abstract 29 stimulated by omega-6 vs. inhibited by omega-3 genistein fatty acids 225-237 in breast cancer chemoprevention models 169- monoterpenes 179 in mammary chemoprevention models 191-197 Gompertz function in analysis of tumor growth parameters in neoadjuvant chemotherapy xenograft models 303-312 abstracts 27,74-76 growth factors nuclear matrix proteins abstracts 112-113 HET and growth regulation — abstract 29 growth kinetics nutrition in design of animal model experiments on see diet cytotoxic agents 255-278 quantitation and Gompertzian analysis in oncogenes xenograft models 303-312 abstracts 89-92 outreach imaging abstracts 64 abstracts 99-100 immunology p53 and immunotherapy — abstracts 67-69 and p21, abberrant expression — abstract 29 insulin patient management in caloric restriction and inhibition of mammary abstracts 77-79 carcinogenesis 161-167 perillyl alcohol isoflavonoids prevention and chemotherapeutic actions in in breast cancer chemoprevention models 169- animal models 191-197 179 personality laboratory animals behavioral correlates of breast cancer risk — colony management in cancer research 313-331 human and animal studies 143-159 338 Subject index, Vol. 46 physical activity screening effects of duration and intensity on mammary abstracts 63-64 carcinogenesis 135-141 serum markers predictive factors abstracts 62-63 abstracts 64-67 soy isoflavonoids prevention in chemoprevention models 169-179 abstracts 81 statistics see also chemoprevention in design and analysis of animal model progesterone receptors experiments on cytotoxic drugs 255-278 abstracts 48-50 reivew of experimental design and data analysis prognostic factors of in vivo studies 279-302 abstracts 103-107 stress methods — abstracts 41-42 behavioral correlates of breast cancer risk — promotion human and animal studies 143-159 by dietary omega-6 fatty acids 225-237,239-246 stromelysin- | protein kinase C in mammary tumor formation — abstract 28 and mechanism of risk caused by high maternal surgery fat intake 191-214 abstracts 51-52 psychosocial factors synergy animal model studies — overview 117-133 determination in animal model experiments on behavioral correlates of breast cancer risk — cytotoxic agents 255-278 human and animal studies 143-159 psychosocial studies taxanes abstracts 76-77 abstracts 23 treadmill running quality assurance animal model of effects of exercise on of animals and tumor cells in animal models for mammary carcinogenesis 135-14] cancer research 313-331 tumor biology abstracts 107-109 radiation therapy tumor cell biology abstracts 36-37 abstracts 46-48 repeated measures tumor growth in statistical approaches and data analysis of in see growth kinetics vivo studies 279-302 tumor suppressor genes retinoids abstracts 89-92 in mammary chemoprevention models 181-189 regression by Targretin ™ (LGD1069) — abstract 24 vaccines risk to prevent progression of HER-2/neu-expressing and high maternal fat intake, in utero estrogenic tumors abstract 24 environment 191-214 veterinary medicine risk factors animal colony management in cancer research abstracts 82 313-331 San Antonio Breast Cancer Symposium — 1997 xenografts abstracts 23-113 quantitation and Gompertzian analysis of growth program 1-2] parameters 303-312